Brachytherapy Market Report

Brachytherapy Market Analysis By Type (High Dose Rate Brachytherapy, Low Dose Rate Brachytherapy), By Application (Prostate, Gynecological, Breast), By Region And Segment Forecasts, 2018 - 2025

  • Published Date: Sep, 2017
  • Base Year for Estimate: 2016
  • Report ID: GVR-1-68038-618-9
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 100

Industry Insights

The global brachytherapy market size was valued at around USD 312.2 million in 2017 and is expected to grow at a CAGR of over 4.76 % over the forecast period. This growth can be attributed to dynamic innovations and technological advancements, such as Halcyon, an image-guided volumetric intensity modulated radiotherapy device by Varian Medical Systems.

U.S. brachytherapy market

Majority of the low- and middle-income countries lack access to cancer treatment, which is expected to provide wide opportunities for brachytherapy firms. The market is anticipated to witness technological breakthroughs and increasing efficiency for treating various types of cancer during the forecast period.

For instance, in June 2016, Elekta AB introduced Venezia Advanced Gynecological Applicator for treatment of advanced stage cervical cancer, andwas used for the first time to treat a patient in Germany in April 2017. In addition, Asia Pacific’s first cervical cancer patient was treated with Venezia in June 2017.

Another factor driving growth of brachytherapy globally is availability of favorable reimbursement pathways and funding to provide quality healthcare facilities in low- and middle-income countries. Supportive pathways, such as National Health Insurance (NHI) Program and private healthcare reimbursement systems, cater the basic healthcare needs of low- and middle-income countries.

Unhealthy lifestyle is likely to increase the incidence rate of cancer and other lifestyle disorders. The WHO estimated a total of 14 million new cancer cases worldwide and 8.8 million deaths, of which 70% of deaths occur in low- and middle-income countries.

Type & Application Insights

The brachytherapy market on the basis of type has been segmented into High-Dose Rate (HDR) brachytherapy and Low-Dose Rate (LDR) brachytherapy. HDR brachytherapy dominated the market in 2016. This can be attributed to easy access to the therapy and its ability to be implanted temporarily. Thus, duration of treatment is lesser as compared to LDR brachytherapy, in which seeds are permanently implanted and the radiation source is inside the patient’s body.

Application segment comprises prostate cancer, breast cancer, and gynecological cancer. The breast cancer segment is anticipated to witness maximum growth during the forecast period. According to American Cancer Society, breast cancer is the most common cancer in women worldwide, and in 2017, there will be 252,710 new breast cancer cases in the U.S. alone.

Prostate cancer is another segment expected to grow at a rapid rate due to wide usage of brachytherapy for prostate cancer since its introduction in the mid-1980s, as well as its increased usage in emerging countries.

Global brachytherapy market

Regional Insights

North America dominated the market in 2016 as the region is an early adopter of new technology, as well as owing to technological advancements in brachytherapy and local presence of market players in the U.S. On the other hand, Asia Pacific is anticipated to witness fastest growth in the coming years owing to rapidly evolving healthcare infrastructure and growing incidence of cancer.

Increasing urbanization, expanding health insurance market with companies such as NHI, geriatric population, and developments in healthcare are major drivers resulting in the growth of brachytherapy in Asia Pacific. Furthermore, increase in number of patients and healthcare expenditure is expected to promote the region as a key destination for brachytherapy companies.

Competitive Insights

Some of the keymarket players are Eckert & Ziegler BEBIG; IsoRay Medical, Inc.; Elekta AB (pub); Theragenics Corporation; C.R. Bard, Inc.; CIVCO Medical Solutions; Huiheng Medical, Inc.; Sun Nuclear Corporation; iCAD, Inc.; and Varian Medical Systems, Inc.

Players are undertaking mergers & acquisitions and introducing technologically advanced products to enhance their product portfolio and gain market share..In August 2016, Eckert & Ziegler acquired BrachySolutions BVBA, one of Europe’s largest prostate seeds distributors. This acquisition has enabled Eckert & Ziegler to secure a strong position in Europe as a seed manufacturer.

In September 2011, Elekta acquired Nucletron, a world leader in brachytherapy treatment delivery and planning. In September 2013, Nucletron introduced Esteya, a new electronic brachytherapy solution for treatment of skin cancer.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2016

Forecast period

2017 - 2025

Market representation

Revenue in USD Million & CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Country scope

U.S., Canada, UK, Germany, China, Japan, Brazil, Mexico, and South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025. For this study, Grand View Research has segmented the brachytherapy market based on type, application, and region:

  • Type (Revenue, USD Million, 2014 - 2025)

    • High Dose Rate (HDR) Brachytherapy

    • Low Dose (LDR) Brachytherapy

  • Application (Revenue, USD Million, 2014 - 2025)

    • Prostate cancer

    • Gynecological cancer

    • Breast cancer

    • Other cancers

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • United Kingdom

      • Germany

    • Latin America

      • Brazil

      • Mexico

    • Asia Pacific

      • China

      • Japan

      • India

    • Middle East Asia

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $7,950
Enterprise Access - $9,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified